EUVIMEDOpdag EUVIMED
Crossref

ALDOB suppresses the activity of CD8 + T cells in colorectal cancer via the WNT signaling pathway

Jinwei Liu, Chao Hu, Yuan Jin

Immunology & Cell Biology · 2025

DOI: 10.1111/imcb.12853 ↗

At a glance

Journal article in Immunology & Cell Biology, 2025. Written by Jinwei Liu and 2 co-authors. Institution: Department of Gastrointestinal Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. Major MEDLINE topics: Colorectal Neoplasms, CD8-Positive T-Lymphocytes, Wnt Signaling Pathway, Fructose-Bisphosphate Aldolase. Cited 3 times so far (Crossref); 27 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The glycolytic enzyme, fructose‐1,6‐bisphosphate aldolase B (ALDOB), is recognized for its key role in shaping tthe umor immune microenvironment. However, the precise ways in which it influences the CD8 + T cell immune response in colorectal cancer (CRC) are still largely unknown. This study is designed to elucidate the interplay between ALDOB and the immune system in CRC. We analyzed the high expression of ALDOB in CRC tissues and cells through bioinformatics, clinical samples and in vitro experiments, finding that it promoted tumor progression. Its high expression was negatively correlated with CD8 expression and positively correlated with PDL1 expression. Further cell experiments revealed that ALDOB overexpression enhanced the expression of WNT signaling pathway‐related proteins (β‐catenin and c‐myc), which in turn promoted PDL1 expression in CRC cells, inhibiting the proliferation and killing effect of CD8 + T cells in co‐culture systems. Our findings disclose how ALDOB influences CD8 + T cell recruitment and antitumor immune function, proposing it as a potential target for the treatment of CRC.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsCD8-Positive T-LymphocytesWnt Signaling PathwayFructose-Bisphosphate AldolaseHumansCell Line, TumorCell ProliferationB7-H1 AntigenGene Expression Regulation, NeoplasticFemaleTumor Microenvironmentbeta Catenin

Author keywords

ALDOBCD8+ T cellsPD‐L1WNT signaling pathwaycolorectal cancer

Substances

Fructose-Bisphosphate AldolaseB7-H1 AntigenCD274 protein, humanbeta Catenin

Authors and institutions

  • Department of Gastrointestinal Surgery, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.
  • Department of Reproductive Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.

Cite

APA

Liu, J., Hu, C., & Jin, Y. (2025). ALDOB suppresses the activity of CD8 + T cells in colorectal cancer via the WNT signaling pathway. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12853

Vancouver

Liu J, Hu C, Jin Y. ALDOB suppresses the activity of CD8 + T cells in colorectal cancer via the WNT signaling pathway. Immunology & Cell Biology. 2025. doi:10.1111/imcb.12853

BibTeX
@article{Liu2025,
  author = {Liu, Jinwei and Hu, Chao and Jin, Yuan},
  title = {ALDOB suppresses the activity of CD8 + T cells in colorectal cancer via the WNT signaling pathway},
  journal = {Immunology & Cell Biology},
  year = {2025},
  doi = {10.1111/imcb.12853}
}
Start for free →